Mar 29, 2019 - The index enjoyed quite a positive week even as a yield curve inversion weighed on broader markets.
Mar 28, 2019 - AstraZeneca's (AZN) Forxiga gets approval in Japan for type I diabetes.
Mar 27, 2019 - J&J (JNJ) submits sBLA seeking approval for Darzalex combination regimen in newly-diagnosed, transplant eligible multiple myeloma patient population
Mar 26, 2019 - Bayer (BAYRY) and partner Johnson & Johnson settle about 25,000 claims over blood thinner, Xarelto for $775 million.
Mar 25, 2019 - J&J (JNJ) seeks an approval for Darzalex combo pertaining to the newly diagnosed, transplant-ineligible multiple myeloma patient population in the EU.
Mar 21, 2019 - The big biotech's pivot from multiple sclerosis to Alzheimer's disease was dealt a decisive blow today.
Mar 21, 2019 - Alkermes (ALKS) has an impressive pipeline and is focused on the development of its candidates.
Mar 19, 2019 - These two popular dividend stocks, and one you've probably never heard of, should fit a retiree's portfolio.
Mar 15, 2019 - Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others.
Mar 15, 2019 - J&J (JNJ) files sBLA seeking approval for Darzalex combination regimen in newly- diagnosed, transplant ineligible multiple myeloma patient population.